ABSTRACT
In a joint initiative by the boards of the German Society for Rheumatology (DGRh) and the Association of Rheumatology Clinics (VRA) the European "standards of care" for rheumatoid arthritis, recently suggested by the European Musculoskeletal Conditions Surveillance and Information Network (eumusc.net) and supported by the European League Against Rheumatism (EULAR), were translated and annotated. The recommendations include aspects of the management of the disease, actual medical care, and access to information - this includes all types of support people with RA need, and, last but not least communication of the necessary knowledge. Furthermore, health care structures such as the availability of medical staff with relevant expertise are also important.
Subject(s)
Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/therapy , Delivery of Health Care/standards , Practice Guidelines as Topic , Rheumatology/standards , Europe , Evidence-Based Medicine , Germany , Humans , Translating , Treatment OutcomeABSTRACT
In 2015 EULAR published recommendations for patient education of people with inflammatory arthritis. The recommendations included two superior principles and eight recommendations based on the level of evidence and expert knowledge. The German translation of the recommendations was evaluated by 15 German experts. Experts graded the strength of the recommendations (SOR) on an 11 point numerical rating scale (from 0 = no agreement to 10 = total agreement). The mean score was 8,8 ± 0,49.
Subject(s)
Arthritis/diagnosis , Arthritis/therapy , Patient Education as Topic/standards , Practice Guidelines as Topic , Rheumatology/standards , Translating , European Union , Germany , Physician's RoleABSTRACT
From the perspective of patients with rheumatic diseases, the reduction of inflammatory disease activity alone is not a sufficient treatment goal. In addition the functional health and participation also have to be improved. Starting with the first symptoms the empowerment for the self-management of the disease is important for the patients; therefore, the established treat to target-strategy has to be expanded by the functional dimension to treat to participation. The position paper of the German Society for Rheumatology (GSR) summarizes the relevant fields of the multiprofessional action that is frequently necessary. This includes the acquirement of function-related competencies during training, further education and advanced training as well as implementation in the everyday practice of patient care. Furthermore, the GSR acknowledges the need for research related to functional and sociomedical consequences of rheumatic diseases and to individual and combined function-related programs in outpatient and inpatient care in rheumatology.
Subject(s)
Activities of Daily Living/psychology , Quality of Life/psychology , Rheumatic Diseases/psychology , Rheumatic Diseases/therapy , Rheumatology/standards , Germany , Humans , Musculoskeletal Diseases/diagnosis , Musculoskeletal Diseases/psychology , Musculoskeletal Diseases/therapy , Outcome Assessment, Health Care/standards , Practice Guidelines as Topic , Recovery of Function , Rheumatic Diseases/diagnosisABSTRACT
Recent Deutsche Gesellschaft für Rheumatologie (DGRh, German Society of Rheumatology) guidelines emphasized the significance of coordinated multidisciplinary care and rehabilitation of patients with inflammatory rheumatic diseases. Nationwide data from the German pension insurance funds showed that inpatient rehabilitation due to rheumatoid arthritis (RA) varied by a factor of 2.6 between the different German states. From 2000 to 2012 rehabilitation measures were reduced by one third, most significantly in men with ankylosing spondylitis (AS). Rehabilitation measures because of RA or AS were provided up to 14 times more frequently by the German statutory pension insurance scheme compared with a large compulsory health insurance which is responsible for rehabilitation measures after retirement. In rehabilitation centers with high numbers of patients with inflammatory rheumatic diseases, higher structural and process quality were demonstrated. In 2011 a total of 40 % of RA patients in the national database of the collaborative arthritis centers showed medium or severe functional limitations. Among these disabled RA patients inpatient rehabilitation was reduced by about 50 % between 1995 and 2011. Out of all RA patients from outpatient rheumatology care with severe functional limitations 38 % had no functional restoration therapy within the previous 12 months with a high variation between rheumatologists. Experiences from other European countries may inspire German rheumatologists and other involved health professionals to initiate a wider range of rehabilitative interventions in the future.
Subject(s)
Needs Assessment/statistics & numerical data , Rehabilitation/statistics & numerical data , Rehabilitation/trends , Rheumatic Diseases/epidemiology , Rheumatic Diseases/rehabilitation , Rheumatology/statistics & numerical data , Rheumatology/trends , Female , Germany/epidemiology , Humans , Incidence , Male , Sex DistributionABSTRACT
The first further education training program of the German Society of Rheumatology (DGRh) was an important milestone in further training in rheumatology. The workshop presented approaches on how to interest and gain students and young physicians for rheumatology and presented the possibilities planned by the DGRh in cooperation with partner organizations and the Rheuma Academy for improvement of further training in rheumatology and the potential to benefit inpatient further training. Many of the projects are dependent on financial support especially by industry. In this article the most important theses and arguments from the individual lectures will be presented.
Subject(s)
Academies and Institutes , Education, Medical, Continuing , Education, Medical, Graduate , Rheumatology/education , Societies, Medical , Career Choice , Curriculum , Education , Education, Medical, Continuing/economics , Education, Medical, Graduate/economics , Financing, Government , Forecasting , Germany , Health Services Needs and Demand/trends , Humans , National Health Programs/economics , Training Support , Universities/economics , WorkforceABSTRACT
Capillaroscopy has high diagnostic and prognostic value in autoimmune connective tissue diseases, in particular systemic sclerosis (SSc). Our working group has developed a consensus on nomenclature, technical equipment, procedure, and diagnostic interpretation of results. The following are required: binocular microscopes with at least 20-/50- and 160-/200-fold magnification and digital archiving. Documentation of defined findings is mandatory. The simultaneous occurrence of, e.g. caliber variations, ectasia, ramifications, elongation (length > 350 microm), torsion (at least two crossing segments per capillary loop), sludge, hemorrhage, and edema is of pathological significance. The isolated occurrence of bushy capillaries (multiple ramifications), thrombosis, giant capillary (capillary lumen > 50 microm), and avascular areas also indicates disease. The latter two findings are highly specific for SSc. Other findings are consistent with connective tissue diseases. These standardized definitions increase quality and comparability of nailfold capillaroscopy in Germany.
Subject(s)
Connective Tissue Diseases/diagnosis , Microscopic Angioscopy/standards , Raynaud Disease/diagnosis , Scleroderma, Systemic/diagnosis , Terminology as Topic , Adolescent , Age Factors , Antiphospholipid Syndrome/classification , Antiphospholipid Syndrome/diagnosis , Capillaries/pathology , Child , Connective Tissue Diseases/classification , Dermatomyositis/classification , Dermatomyositis/diagnosis , Disease Progression , Documentation/methods , Documentation/standards , Humans , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/pathology , Microscopic Angioscopy/instrumentation , Microscopic Angioscopy/methods , Prognosis , Raynaud Disease/classification , Reference Standards , Reference Values , Scleroderma, Systemic/classificationSubject(s)
Evidence-Based Medicine , Fibromyalgia/rehabilitation , Adrenergic Uptake Inhibitors/therapeutic use , Analgesics/therapeutic use , Antidepressive Agents/therapeutic use , Combined Modality Therapy , Consensus Development Conferences as Topic , Cross-Sectional Studies , Duloxetine Hydrochloride , Exercise Therapy , Fibromyalgia/epidemiology , Humans , Practice Guidelines as Topic , Pregabalin , Selective Serotonin Reuptake Inhibitors/therapeutic use , Thiophenes/therapeutic use , gamma-Aminobutyric Acid/analogs & derivatives , gamma-Aminobutyric Acid/therapeutic useSubject(s)
Consensus , Evidence-Based Medicine , Osteoarthritis/therapy , Delphi Technique , Humans , Pain Management , Placebo EffectABSTRACT
Dermatomyositis (DM) is a systemic inflammatory disease involving skin, muscles and other organs. Immunologically mediated inflammation of small vessels leads to vascular damage, especially of the muscular tissue. Typically DM presents clinically with DM-type local or generalized rash and proximal muscular weakness. Laboratory signs of muscular damage (elevated serum CK, myoglobinuria) may be initially absent. Magnetic resonance tomography frequently shows edema of the involved muscles, while electromyography shows a myopathic pattern with spontaneous activity. Muscle biopsy from involved muscle with histological, immunohistological, histochemical and possibly electron-microscopic examination confirms the diagnosis of inflammatory muscle disease and furthermore of DM-specific muscular findings. Typical findings include the deposition of 5b-9 complement components (membrane attack complex) at the capillaries, perifascicular inflammatory infiltrates composed predominantly of CD4+ T-lymphocytes, B-lymphocytes and plasmacytoid dendritic cells, endothelial swelling and damage, loss of capillaries with perifascicular atrophy and tubuloreticular endothelial inclusions on electron-microscopic examination. Detection of myositis-specific autoantibodies is especially helpful in the diagnosis of early and atypical cases with features of overlapping disease.
Subject(s)
Dermatomyositis/diagnosis , Dermatomyositis/immunology , Muscle, Skeletal/immunology , HumansABSTRACT
BACKGROUND: Digital ulcers (DU) are a major complication in the course of systemic sclerosis (SSc). In recent years, efficacious, but expensive therapies (e.g. iloprost, sildenafil, bosentan) have been shown to improve healing or to reduce the recurrence of DU. For optimal management it would be useful to identify the risk factors for DU. Such statistical analyses have been rare because they require a high number of patients. OBJECTIVES: To identify potential risk factors for DU in patients with SSc. METHODS: We used the registry of the German Network for Systemic Scleroderma and evaluated the data of 1881 patients included by August 2007. We assessed potential risk factors for DU by comparing patients with (24.1%) and without active DU at time of entry (75.9%). RESULTS: Multivariate analysis revealed that male sex, presence of pulmonary arterial hypertension (PAH), involvement of the oesophagus, diffuse skin sclerosis (only when PAH was present), anti-Scl70 antibodies, young age at onset of Raynaud's phenomenon (RP), and elevated erythrocyte sedimentation rate (ESR) significantly impacted on the appearance of DU. Certain combinations increased the patients' probability of presenting with DU, with the highest probability (88%) for male patients with early onset of RP, ESR>30 mm h(-1), anti-Scl70 antibodies and PAH. Patients with DU developed RP, skin sclerosis and organ involvement approximately 2-3 years earlier than patients without DU. CONCLUSIONS: The results reveal possible risk factors for the occurrence of DU in SSc. As DU are prone to local complications, prophylactic vasoactive treatment for patients presenting with these factors may be justified.
Subject(s)
Raynaud Disease/etiology , Scleroderma, Systemic/etiology , Ulcer/complications , Adult , Female , Fingers , Germany , Humans , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Raynaud Disease/psychology , Raynaud Disease/therapy , Risk Assessment , Scleroderma, Systemic/psychology , Scleroderma, Systemic/therapy , Socioeconomic Factors , Ulcer/psychology , Ulcer/therapyABSTRACT
OBJECTIVES: In SSc, diagnosis and classification is based mainly on skin sclerosis. Herein, we investigated in a large multicentre cohort, to what extent skin sclerosis reflects organ involvement and additional clinical symptoms. METHODS: A total of 1200 SSc patients from the register of the German Systemic Sclerosis Network (DNSS), classified as either lcSSc or dcSSc, were analysed for their serological characteristics, clinical symptoms and organ manifestations in relation to skin involvement measured by the modified Rodnan skin score (mRSS). RESULTS: SSc patients with different mRSS did not differ significantly in their disease duration and in most of the clinical symptoms. They showed a similar distribution of most organ manifestations such as pulmonary arterial hypertension as well as cardiac, renal and nervous system involvement. More severe skin thickening was found to be associated with pulmonary fibrosis and gastrointestinal symptoms, as well as with digital ulcers and musculoskeletal involvement. CONCLUSIONS: In patients with SSc, potentially life-threatening complications and clinical symptoms with high impact on the quality of life occur independently from the extent of skin sclerosis. The diagnosis in SSc patients with a low mRSS could be missed or they could be insufficiently treated.
Subject(s)
Scleroderma, Systemic/pathology , Skin/pathology , Cohort Studies , Contracture/etiology , Deglutition Disorders/etiology , Humans , Hypertension, Pulmonary/etiology , Pulmonary Fibrosis/etiology , Scleroderma, Diffuse/complications , Scleroderma, Diffuse/pathology , Scleroderma, Systemic/complications , Severity of Illness Index , Skin Ulcer/etiology , Time FactorsABSTRACT
OBJECTIVE: Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and therapeutic management. To improve the detection and follow-up of patients presenting with different disease manifestations, an interdisciplinary registry was founded with contributions from different subspecialties involved in the care of patients with SSc. METHODS: A questionnaire was developed to collect a core set of clinical data to determine the current disease status. Patients were grouped into five descriptive disease subsets, i.e. lcSSc, dcSSc, SSc sine scleroderma, overlap-syndrome and UCTD with scleroderma features. RESULTS: Of the 1483 patients, 45.5% of patients had lcSSc and 32.7% dcSSc. Overlap syndrome was diagnosed in 10.9% of patients, while 8.8% had an undifferentiated form. SSc sine scleroderma was present in 1.5% of patients. Organ involvement was markedly different between subsets; pulmonary fibrosis for instance was significantly more frequent in dcSSc (56.1%) than in overlap syndrome (30.6%) or lcSSc (20.8%). Pulmonary hypertension was more common in dcSSc (18.5%) compared with lcSSc (14.9%), overlap syndrome (8.2%) and undifferentiated disease (4.1%). Musculoskeletal involvement was typical for overlap syndromes (67.6%). A family history of rheumatic disease was reported in 17.2% of patients and was associated with early disease onset (P < 0.005). CONCLUSION: In this nationwide register, a descriptive classification of patients with disease manifestations characteristic of SSc in five groups allows to include a broader spectrum of patients with features of SSc.
